FluoSphera

Don't let the drug decide for you

Geneva, Switzerland · Founded 2021

Headquarters
Geneva
Employees
1–10
Founded
2021
Business Model
B2B
Last Round
SeedJan 2026
Rounds
1

About

FluoSphera is a Swiss biotech company developing a human multi-tissue platform for next-generation drug discovery. Its technology uses encapsulated organ-like microtissues to mimic systemic clinical drug responses, enabling high-throughput, human-relevant in vitro drug profiling before clinical trials. The company is headquartered in Geneva, Switzerland, with a US presence in Boston.

Summary

FluoSphera is a Biotech company based in Geneva, Switzerland, founded in 2021. Its most recent funding was a Seed round in Jan 2026. Investors include Wake-Up Capital, Inovexus and Stamco AG.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedSeed RoundJan 2026

Investors

Similar Companies

ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

FluoSphera on Indexed.vc
<a href="https://indexed.vc/companies/fluosphera"><img src="https://indexed.vc/api/badge/company/fluosphera" alt="FluoSphera on Indexed.vc" width="260" height="76" /></a>